Several naturally occurring mutations of ghrelin receptor, such as A204E and F279L, decrease the basal activity of the receptor and have been found to associate with obesity, diabetes, and short stature14, which led to the idea of ghrelin receptor being an attractive therapeutic target for these diseases. This evidence concerns the gene GHSR and obesity due to melanocortin 4 receptor deficiency.